AngioDynamics (ANGO) PT Raised to $21 at Piper Jaffray Amid Strong Q2
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
AngioDynamics (ANGO) Tops Q2 EPS by 2c; Boosts Outlook
January 8, 2015 4:07 PM ESTAngioDynamics (NASDAQ: ANGO) reported Q2 EPS of $0.17, $0.02 better than the analyst estimate of $0.15. Revenue for the quarter came in at $92.1 million versus the consensus estimate of $90.9 million.
AngioDynamics sees FY2015 EPS of $0.66-$0.72, versus the consensus of $0.69. AngioDynamics sees FY2015 revenue of $362-368 million, versus the consensus of $366.2 million.
"The strong sales momentum we established last fiscal year continued in the second quarter of FY15 as... More
